Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3032567	s-hbvnh	— (—)	1018	1647	100.00%	Distribution not available
3032567	-hbvnh	— (—)	82	111	100.00%	Distribution not available
3032567	p-hbvnh	— (—)	47	47	100.00%	Distribution not available
3032567	s-hbvnh	iu/ml (iu/ml)	32	72	37.50%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Viral hepatitis, IBD co-morbidity

180

51.98

312.97

3.9

1.1

25385001.77

—

iu/ml

—

Viral hepatitis

189

31.86

289.66

3.8

1.2

25385001.77

—

iu/ml

—

Other viral hepatitis

175

35.24

276.26

4.0

1.2

25385001.77

—

iu/ml

—

Chronic viral hepatitis

160

39.10

259.68

4.3

1.1

25385001.77

—

iu/ml

—

Condition for Implicit Sepsis (Organ dysfunction codes)

228

694

2.32

28.89

1.3

1.7

—

30000346.82

iu/ml

—

Implicit Sepsis

217

672

2.37

28.86

1.3

1.7

—

30000346.82

iu/ml

—

Implicit Sepsis

201

623

2.44

28.79

1.3

1.7

—

30000346.82

iu/ml

—

Bacterial Sepsis

131

394

2.85

26.31

1.3

1.6

—

602.40

iu/ml

—

Condition for Implicit Sepsis (Organ dysfunction codes)

230

730

2.18

24.95

1.4

1.7

—

348.09

iu/ml

—

Substance use, excluding alcohol

234

3.53

24.34

1.3

1.8

—

506.17

—

Ascites

5.54

21.01

1.4

1.8

—

All kidney diseases

234

835

1.92

18.25

1.5

1.6

—

391.46

iu/ml

—

Unspecified jaundice

6.50

16.66

1.1

1.5

—

iu/ml

—

Persons with potential health hazards related to communicable diseases

101

449

2.24

12.90

1.9

1.6

517.00

311.20

iu/ml

—

Human immunodeficiency virus [HIV] disease

14.38

12.81

2.1

1.7

—

iu/ml

—

Other acute viral hepatitis

19.51

11.66

1.3

1.1

—

Human immunodeficiency virus [HIV] disease resulting in other conditions

13.94

11.51

2.2

1.8

—

iu/ml

—

Kela reimbursement Agammaglobulinemia (D80-84)

20.98

11.25

1.2

2.3

—

iu/ml

—

Hypertensive diseases (excluding secondary)

123

363

1.97

10.26

1.4

1.8

—

485.00

iu/ml

—

Other anaemias

418

2.07

9.68

1.8

1.5

—

644.20

iu/ml

—

Inflammatory bowel disease treatment related agents

244

865

1.58

9.54

1.5

1.6

644.20

33000188.20

iu/ml

—

Aplastic and other anaemias

450

1.99

9.16

1.7

1.5

—

644.20

iu/ml

—

Other and unspecified anaemias

416

2.04

9.13

1.8

1.5

—

644.20

iu/ml

—

Second line medication for Crohn's disease

127

714

1.78

8.72

1.4

1.7

—

381.50

iu/ml

—

Hypertensive diseases

170

569

1.69

8.71

1.4

1.7

—

426.88

iu/ml

—

Hypertension

170

569

1.69

8.70

1.4

1.7

—

426.88

iu/ml

—

Unspecified human immunodeficiency virus [HIV] disease

16.77

8.61

1.6

1.0

—

iu/ml

—

Other specific joint derangements/joint disorders

138

508

1.76

8.40

2.1

1.8

273.80

414.89

iu/ml

—

Nonhereditary hypogammaglobulinemia

14.88

8.25

1.2

2.1

—

iu/ml

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

318

1.95

8.18

1.6

1.9

—

555.67

iu/ml

—

Malaise and fatigue

101

432

1.88

8.05

1.6

—

514.00

iu/ml

—

Cholangitis (primary sclerosing, PSC), with reimbursement 202

8.59

7.84

1.2

1.6

—

L04AX Other immunosuppressants

120

690

1.74

7.69

1.5

1.7

—

381.50

iu/ml

—

Cardiovascular diseases (excluding rheumatic etc)

139

468

1.71

7.56

1.5

1.8

—

463.80

iu/ml

—

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

4.00

7.24

1.4

1.2

—

iu/ml

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

284

2.13

7.11

1.9

1.6

—

651.71

iu/ml

—

Depression medications

157

2.15

6.87

1.5

1.6

—

878.80

iu/ml

—

Dissocial personality disorder

8.27

6.36

1.1

1.7

—

Autoimmune hepatitis

11.33

6.34

1.3

1.9

—

Other heart diseases

368

1.76

6.19

1.4

1.8

—

485.00

iu/ml

—

Diseases of the digestive system

493

1.78

6.16

1.3

1.6

—

596.40

iu/ml

—

Hepatocellular carcinoma

8.10

5.85

1.2

2.0

—

Osteopathies and chondropathies

109

616

1.65

5.80

1.4

1.6

—

390.56

iu/ml

—

Assault

169

2.32

5.65

1.8

1.7

—

604.60

—

Excluding asthma or asthma-COPD overlap

162

533

1.52

5.53

1.4

1.7

—

539.56

iu/ml

—

Other pulmonary diagnosis

161

533

1.51

5.36

1.4

1.7

—

539.56

iu/ml

—

Reactive arthropathies, FINNGEN

3.41

5.30

2.6

2.0

—

iu/ml

—

Used for control exclusion in common control thyroid runs

213

764

1.41

4.97

1.7

1.6

221.80

609.17

iu/ml

—

Pneumocystosis

6.97

4.97

1.5

1.8

—

Other viral diseases

459

1.71

4.92

1.2

1.7

—

426.13

iu/ml

—

Infections of the skin and subcutaneous tissue

115

735

1.55

4.86

1.5

1.7

—

327.64

iu/ml

—

COPD differential diagnosis

158

534

1.48

4.82

1.3

1.7

—

539.56

iu/ml

—

ILD differential diagnosis

158

534

1.48

4.82

1.3

1.7

—

539.56

iu/ml

—

Hypoplasia of dental enamel

11.62

4.79

1.3

1.0

—

Viral infections characterized by skin and mucous membrane lesions

500

1.66

4.66

1.4

1.6

—

426.88

iu/ml

—

Cutaneous abscess, furuncle and carbuncle

309

1.85

4.63

1.2

1.7

—

604.60

iu/ml

—

6-mercaptopurine

4.55

4.56

1.1

1.8

—

iu/ml

—

Other necrotizing vasculopathies (FG)

4.54

4.55

1.3

2.9

—

Care involving use of rehabilitation procedures

117

708

1.52

4.51

1.5

1.6

—

30000326.36

iu/ml

—

Other reaction to severe stress, and adjustment disorders

433

1.69

4.39

2.1

1.6

—

463.80

iu/ml

—

Colitis, primary sclerosing, strict definition

7.64

4.37

1.1

2.1

—

Genitourinary diseases

130

432

1.51

4.36

2.1

1.7

—

446.80

iu/ml

—

Hepatomegaly and splenomegaly, not elsewhere classified

11.86

4.29

1.7

1.3

—

Need for other prophylactic measures

3.05

4.24

2.0

1.4

—

Need for immunization against other single viral diseases

5.95

4.14

1.2

1.7

—

Other and unspecified nonorganic psychotic disorders

231

1.91

3.99

1.4

1.7

—

601.20

iu/ml

—

Other viral diseases

361

1.71

3.98

1.3

1.8

—

426.13

iu/ml

—

Transport accidents

495

1.57

3.96

1.9

1.8

—

454.27

iu/ml

—

Schizophrenia or delusion, excluding more controls

354

1.71

3.87

1.3

1.7

—

426.13

iu/ml

—

Syncope and collapse

403

1.62

3.83

1.3

1.5

—

514.00

iu/ml

—

Asymptomatic human immunodeficiency virus [HIV] infection status

12.29

3.78

1.7

1.0

—

iu/ml

—

Disorders of thyroid, IBD co-morbidities

2.35

3.71

1.2

—

Acute sinusitis

597

1.51

3.65

1.5

1.7

—

417.42

iu/ml

—

Neurotic, stress-related and somatoform disorders

166

849

1.37

3.60

1.8

1.6

—

364.50

iu/ml

—

Folate deficiency anaemia

10.15

3.51

1.0

2.7

—

Exposure to other specified factors

139

918

1.39

3.47

1.6

1.7

—

22000340.20

iu/ml

—

Other anxiety disorders

482

1.53

3.44

1.6

—

463.80

iu/ml

—

Cholecystitis

126

2.15

3.40

1.1

1.6

—

Other secondary gonarthrosis

3.11

3.37

1.2

1.8

—

Symptoms and signs involving the urinary system

133

728

1.39

3.28

1.8

1.6

—

30000346.82

iu/ml

—

Other heart diseases, wide

170

773

1.35

3.27

1.3

1.7

—

304.42

iu/ml

—

Unspecified fall

598

1.48

3.24

1.3

1.7

—

384.11

iu/ml

—

Anxiety (asthma-related co-morbidities)

109

587

1.44

3.22

1.5

1.7

—

423.45

iu/ml

—

Bipolar affective disorders

221

1.81

3.17

1.6

1.9

—

485.00

—

Primary biliary cholangitis (PBC)

4.54

3.12

1.0

1.6

—

Injuries to the hip and thigh

490

1.50

3.04

1.6

—

507.17

iu/ml

—

Specific personality disorders

284

1.69

3.03

1.5

1.8

—

555.67

—

Hallux rigidus

2.30

3.00

1.2

2.1

—

Injury, poisoning and certain other consequences of external causes

103

356

1.45

2.99

1.2

1.8

—

607.43

iu/ml

—

Any operation in hilmo

5.86

2.96

2.3

1.4

—

External causes of morbidity and mortality

119

424

1.41

2.93

1.3

1.7

—

607.43

iu/ml

—

Internal derangement of knee

347

1.61

2.92

1.5

1.9

—

362.86

iu/ml

—

Short stature, not elsewhere classified

4.20

2.90

1.0

1.2

—

Disorders of adult personality and behaviour

351

1.60

2.85

1.7

—

485.00

—

Accidents

151

565

1.34

2.78

1.3

1.7

—

454.27

iu/ml

—

Pain, not elsewhere classified

269

1.67

2.76

1.9

1.6

—

610.60

—

Somnolence, stupor and coma

3.25

2.72

2.7

1.6

—

Other specified and unspecified disorders of eyelid

6.05

2.70

1.0

1.9

—

Other symptoms and signs involving cognitive functions and awareness

480

1.46

2.62

1.3

1.6

—

490.20

iu/ml

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

377

1.54

2.57

1.2

1.6

—

604.60

—

Leukaemia of unspecified cell type

7.23

2.55

1.2

2.3

—

Alcohol induced polyneuropathy

7.22

2.55

1.2

1.3

—

Failed attempted abortion

7.20

2.55

1.0

2.3

—

iu/ml

—

Early syphilis

5.51

2.55

2.3

2.1

—

Fall on same level involving ice and snow

700

1.39

2.52

1.5

1.7

—

348.09

—

All anxiety disorders

110

639

1.36

2.48

1.5

1.6

—

391.92

iu/ml

—

Acute tubulo-interstitial nephritis

605

1.38

2.45

1.5

1.6

—

465.38

iu/ml

—

Schizophrenia, schizotypal and delusional disorders

406

1.50

2.44

1.3

1.7

—

444.14

iu/ml

—

Recurrent or chronic depression

368

1.45

2.44

1.4

1.8

—

547.00

iu/ml

—

Schizophrenia or delusion

407

1.50

2.42

1.3

1.7

—

444.14

iu/ml

—

Cardiac arrhythmias

106

504

1.37

2.39

1.4

1.7

—

429.12

—

Hypoplasia of dental enamel , including avohilmo

3.25

2.31

1.2

1.4

—

Unspecified mental disorder

511

1.43

2.28

1.3

1.7

—

426.13

iu/ml

—

Early syphilis

4.66

2.27

2.3

2.0

—

Diseases of the respiratory system

117

439

1.34

2.20

1.4

1.7

—

636.57

iu/ml

—

Intracranial trauma

105

551

1.34

2.16

1.5

1.7

—

195.33

iu/ml

—

DVT of lower extremities and pulmonary embolism

441

1.45

2.15

1.2

1.7

—

644.20

iu/ml

—

Low back pain

127

704

1.30

2.08

1.7

1.6

—

36666963.44

iu/ml

—

Habitual aborter

4.02

2.04

1.8

1.1

—

Pregnancy with abortive outcome

379

1.35

2.02

1.6

—

420.17

iu/ml

—

Venous thromboembolism

581

1.36

1.99

1.4

1.6

—

558.50

iu/ml

—

Candidiasis

312

1.51

1.97

1.8

1.6

—

658.40

iu/ml

—

Acute upper respiratory infections

173

859

1.24

1.96

1.4

1.6

—

25385000.69

iu/ml

—

Kela-code for severe mental illness

461

1.41

1.95

1.3

1.7

—

426.13

iu/ml

—

Residual foreign body in soft tissue

2.45

1.93

1.1

1.3

—

Chronic pancreatitis

121

1.82

1.88

1.3

1.7

—

Other diseases of pancreas

2.09

1.86

1.3

1.8

—

Assault by sharp object

3.35

1.75

1.7

—

Disorders of sclera, cornea, iris and ciliary body

679

1.31

1.72

1.8

1.7

—

348.09

iu/ml

—

Lifestyle-related condition

3.88

1.72

1.0

2.0

—

Personal history of risk-factors, not elsewhere classified

3.87

1.72

1.0

1.9

—

Carcinoma in situ of skin of lower limb, including hip

3.86

1.71

1.2

1.0

—

Persons encountering health services in other circumstances

464

1.37

1.68

1.5

1.7

—

579.13

—

Trigger finger

146

0.41

1.63

1.2

1.7

—

Other factor of the environment

3.60

1.62

1.0

1.9

—

Schizophrenia

198

1.57

1.59

1.4

1.7

—

604.60

—

Traumatic subarachnoid haemorrhage

2.70

1.58

1.1

1.9

—

186

801

1.20

1.55

1.5

1.6

—

417.42

iu/ml

—

Diffuse brain injury

2.43

1.54

2.1

1.8

—

Disorders of iron metabolism

3.35

1.52

1.0

2.0

—

Routine general health check-up of defined subpopulation

3.34

1.52

1.0

1.1

—

Excessive earwax

675

0.72

1.52

1.3

1.6

—

430.38

iu/ml

—

Erosion of teeth , including avohilmo

299

1.44

1.50

1.3

1.7

—

485.00

—

Type of accident

343

1.40

1.45

1.3

1.6

—

604.60

—

Other viral diseases, not elsewhere classified

316

1.42

1.45

1.1

1.7

—

485.00

—

Diseases of male genital organs

392

1.28

1.45

1.8

1.7

—

363.67

iu/ml

—

Urticaria

335

1.40

1.44

1.1

1.6

—

666.60

—

Concussion

540

1.28

1.43

1.7

—

195.33

iu/ml

—

Adrenocortical insufficiency

2.42

1.39

1.1

1.7

—

Intracranial injury

700

1.26

1.36

1.7

1.6

—

376.80

iu/ml

—

Ectropion of eyelid

2.51

1.30

1.0

1.7

—

Complications predominantly related to the puerperium

268

0.60

1.27

1.4

1.7

—

500.20

—

Fracture at wrist and hand level

441

1.31

1.22

1.3

1.6

—

518.17

—

Toxic effect of alcohol

2.64

1.21

1.4

1.9

—

Panic disorder

164

1.53

1.20

1.7

1.6

—

612.80

iu/ml

—

Injuries to the thorax

550

1.27

1.17

1.3

1.6

—

604.60

iu/ml

—

Urticaria and erythema

428

1.31

1.16

1.2

1.7

—

426.88

—

Nonsuppurative otitis media

236

1.39

1.15

1.3

1.6

—

697.67

iu/ml

—

Other predominantly sexually transmitted diseases, not elsewhere classified

191

1.47

1.13

1.5

1.8

—

560.67

iu/ml

—

Valvular heart disease excluding rheumatic fever

399

1.27

1.10

1.2

1.7

—

616.20

iu/ml

—

Other and unspecified tonsillitis

377

1.29

1.10

1.7

1.8

—

509.89

—

Other facial nerve disorders

2.39

1.09

1.2

1.6

—

Testicular dysfunction

1.96

1.09

1.4

1.5

—

Focal brain injury

1.87

1.07

1.7

1.6

—

Obesity due to excess calories

570

1.25

1.03

1.5

1.6

—

464.40

iu/ml

—

Infective bursitis

2.28

1.03

1.0

1.4

—

Testicular hypofunction

2.06

1.03

1.4

1.6

—

2.28

1.03

1.0

1.1

—

Impotence

1.89

1.01

1.1

1.4

—

Osteoporosis with pathological fracture (FG)

2.00

1.00

1.0

2.3

—

iu/ml

—

Fitting and adjustment of other devices

322

0.70

0.99

1.8

1.5

—

616.20

iu/ml

—

Polyarthrosis

114

1.55

0.99

1.1

1.9

—

Spondylosis

520

1.22

0.95

1.5

—

66000216.20

iu/ml

—

Nonorganic sleeping disorders, excluding more controls

216

1.39

0.95

1.8

—

485.00

iu/ml

—

Benign neoplasm: Colon

585

1.22

0.95

2.0

1.6

—

270.20

iu/ml

—

Hordeolum and other deep inflammation of eyelid

1.77

0.94

1.7

1.4

—

Benign neoplasm of colon, rectum, anus and anal canal

650

1.20

0.94

1.8

1.6

—

47143335.86

iu/ml

—

Ischaemic Stroke, excluding all haemorrhages

499

0.79

0.93

1.1

1.7

—

558.50

iu/ml

—

Symptoms and signs involving emotional state

2.07

0.89

1.7

1.8

—

Psoriatic and enteropathic arthropathies

1.58

0.87

1.3

2.2

—

Anisometropia and aniseikonia

2.00

0.87

1.3

1.6

—

Psoriasis (vulgaris), strict definition

2.00

0.87

1.8

1.7

—

Recurrent dislocation of patella

1.82

0.86

1.1

1.7

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

1.63

0.84

1.6

—

iu/ml

—

Inguinal hernia, bilateral

113

0.53

0.83

1.0

1.6

—

Inguinal or femoral hernia, bilateral

115

0.52

0.82

1.0

1.6

—

Other symptoms and signs involving general sensations and perceptions

1.88

0.82

1.0

1.4

—

Injuries to the neck

275

1.31

0.81

2.2

1.7

—

515.83

iu/ml

—

Non-rheumatic valve diseases

397

1.22

0.81

1.2

1.7

—

616.20

iu/ml

—

Congenital malformations of great arteries

0.00

0.79

0.0

1.5

—

Pyogenic arthritis

1.67

0.78

1.3

2.3

—

iu/ml

—

Respiratory and cardiovascular disorders specific to the perinatal period

2.13

0.75

2.6

1.6

—

Muscle strain

2.09

0.74

1.4

1.3

—

Other acute lower respiratory infections

611

1.19

0.74

1.8

1.6

—

381.00

iu/ml

—

Systemic connective tissue disorders

378

1.24

0.73

1.2

1.7

—

664.00

iu/ml

—

Other congenital malformations of circulatory system

2.01

0.72

1.2

1.6

—

Other disorders of adrenal gland

1.80

0.72

1.1

1.8

—

Deviated nasal septum

425

1.22

0.71

1.9

1.7

—

601.40

—

Small fibre neuropathy

1.93

0.70

1.0

1.7

—

iu/ml

—

Other abnormal products of conception

203

1.27

0.70

1.2

1.7

—

500.20

iu/ml

—

Other diseases of lip and oral mucosa

481

1.21

0.69

1.3

1.6

—

487.43

iu/ml

—

Allergic rhinitis

394

0.78

0.69

2.4

1.7

—

426.13

—

Sixth [abducent] nerve palsy

1.86

0.68

1.0

1.7

—

Other cataract

412

1.19

0.68

1.6

1.5

—

iu/ml

—

Disorders of orbit

1.67

0.68

1.1

1.3

—

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

1.53

0.68

1.9

1.3

—

iu/ml

—

Traumatic subdural haemorrhage

122

1.42

0.67

1.0

1.8

—

Arthropathic psoriasis

119

1.43

0.66

1.3

1.8

—

Inflammatory diseases of female pelvic organs

490

1.17

0.66

1.3

1.6

—

365.13

iu/ml

—

Injuries to the shoulder and upper arm

129

922

1.13

0.66

1.7

1.6

—

25384913.38

iu/ml

—

Gestational [pregnancy-induced] hypertension

258

0.73

0.64

1.6

1.7

—

500.20

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

437

0.82

0.62

1.6

—

365.12

—

Entropion and trichiasis of eyelid

1.59

0.61

1.3

2.0

—

Other functional intestinal disorders

504

1.18

0.61

1.3

1.5

—

509.00

—

Temporomandibular joint disorders, including avohilmo

500

1.18

0.61

1.7

1.6

—

512.56

iu/ml

—

Keratitis

434

1.20

0.61

1.9

1.6

—

604.60

iu/ml

—

Periodontal disease, other/unspecified

0.00

0.60

0.0

1.5

—

Lateral epicondylitis

139

0.65

0.60

1.0

1.8

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

457

1.19

0.60

1.6

—

445.00

iu/ml

—

Ptosis of eyelid

105

1.43

0.60

1.0

1.6

—

Psoriatic arthropathies

1.50

0.59

1.4

2.1

—

Examination and encounter for administrative purposes

1.54

0.59

1.5

—

Atopic dermatitis, strict definition with reimbursement

341

1.22

0.59

1.5

1.7

—

740.33

—

Necrosis of pulp, including avohilmo

759

1.14

0.58

1.7

1.6

—

382.54

iu/ml

—

Paralytic strabismus

1.56

0.58

1.0

1.5

—

Hyperaldosteronism

0.00

0.58

0.0

1.8

—

Lesion of plantar nerve

1.51

0.58

1.0

1.9

—

Sleep disorders (combined)

180

859

1.10

0.58

1.6

1.7

530.20

33000245.20

iu/ml

—

Femoral hernia

1.72

0.57

1.2

1.5

—

Autoimmune hyperthyroidism

1.50

0.54

1.2

1.8

—

Fracture of shoulder and upper arm

431

1.18

0.53

1.8

1.7

—

415.88

iu/ml

—

Dentofacial anomalies [including malocclusion]

105

753

1.12

0.52

1.5

1.7

—

389.08

iu/ml

—

Stenosis and insufficiency of lacrimal passages

1.45

0.51

3.0

1.7

—

iu/ml

—

Juvenile arthritis (FINNGEN)

1.50

0.51

1.3

1.6

—

iu/ml

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

460

1.17

0.50

1.5

1.7

—

569.75

—

Hyperfunction of pituitary gland

1.46

0.50

2.7

2.0

—

Spontaneous abortion

337

0.84

0.49

1.7

1.6

—

420.17

iu/ml

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

399

1.16

0.48

1.4

1.6

—

398.71

iu/ml

—

Migraine

525

0.86

0.48

1.3

1.8

—

253.45

iu/ml

—

Sequelae of injuries, of poisoning and of other consequences of external causes

299

1.20

0.47

1.4

1.7

—

604.60

—

Presence of other functional implants

479

1.13

0.45

1.5

1.6

—

270.20

iu/ml

—

Persons encountering health services in circumstances related to reproduction

568

0.89

0.43

1.3

1.7

—

422.75

iu/ml

—

Metatarsalgia

1.37

0.43

1.0

1.6

—

Other enthesopathy of foot (+metatarsalgia)

104

1.35

0.43

1.1

1.6

—

Triptan medication for migraine, min. 3 purchases

553

0.88

0.42

1.1

1.6

—

464.40

iu/ml

—

Abrasion of teeth

396

1.16

0.42

1.5

1.6

—

644.20

—

Injuries to the elbow and forearm

103

821

1.10

0.42

1.3

1.7

—

417.42

—

Vertical strabismus

1.56

0.42

1.0

1.6

—

Hyperprolactinaemia

1.56

0.42

3.0

1.8

—

Fracture of lower leg, including ankle

691

1.12

0.41

1.3

1.7

—

340.36

iu/ml

—

Other disorders originating in the perinatal period

0.00

0.41

0.0

1.7

—

Other abnormal findings in urine

0.00

0.41

0.0

1.8

—

Primary ovarian failure

0.00

0.41

0.0

1.7

—

Third [oculomotor] nerve palsy

0.00

0.41

0.0

1.7

—

Conotruncal defects

0.00

0.40

0.0

1.6

—

Bursitis of shoulder

0.00

0.40

0.0

1.5

—

Procreative management

378

1.15

0.40

1.3

1.8

—

476.71

iu/ml

—

Hyperkinetic disorders, excluding more controls

109

1.32

0.40

1.0

2.0

—

482.57

—

Vasomotor and allergic rhinitis

457

0.86

0.40

2.2

1.8

—

566.00

—

Malignant neoplasm of testis

0.00

0.40

0.0

1.5

—

Venous complications and haemorrhoids in pregnancy

0.00

0.40

0.0

1.6

—

Retinal detachments and breaks

399

1.15

0.39

1.4

1.6

—

270.20

—

SLE (Finngen)

1.43

0.39

1.0

2.0

—

Childhood asthma (age<16), excluding more controls

111

1.28

0.39

1.2

1.9

—

825.00

—

Myositis

0.00

0.39

0.0

1.5

—

Diseases of salivary glands

367

0.84

0.38

1.6

1.5

—

604.60

iu/ml

—

Pregnancy hypertension

396

0.86

0.38

1.3

1.6

—

398.71

—

Fibroblastic disorders

233

1.20

0.38

2.5

1.7

—

Pollen allergy

222

0.80

0.37

3.3

1.6

—

513.00

—

Childhood asthma (age<16)

112

1.27

0.37

1.2

1.9

—

825.00

—

Seronegative rheumatoid arthritis

1.39

0.36

1.7

2.1

—

Lesion of lateral popliteal nerve

1.33

0.33

3.3

1.4

—

Medical treatment for female infertility

184

1.19

0.29

1.6

1.7

—

500.20

iu/ml

—

Statin medication

571

0.93

0.28

1.6

1.7

—

560.67

iu/ml

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

223

1.16

0.28

1.0

1.8

—

482.57

—

Fracture of forearm

641

1.09

0.27

1.4

1.7

—

352.90

—

In situ neoplasms

394

1.12

0.27

2.0

1.7

—

282.00

iu/ml

—

548

0.90

0.26

1.5

1.6

—

426.13

iu/ml

—

Later onset COPD

205

0.85

0.26

1.0

1.6

—

iu/ml

—

Extrapyramidal and movement disorders

415

0.89

0.25

1.4

1.6

—

616.20

iu/ml

—

Irritable bowel syndrome

320

1.13

0.25

1.4

1.6

—

558.83

—

Acute laryngitis and tracheitis

131

1.20

0.24

1.3

1.7

—

601.20

—

Other arrhythmias

612

1.07

0.23

1.5

1.7

—

393.89

iu/ml

—

Later onset COPD, excluding more controls

146

1.16

0.23

1.0

1.6

—

iu/ml

—

Ovarian cyst

251

1.10

0.23

1.1

1.6

—

466.20

iu/ml

—

Other fall from one level to another

274

0.88

0.22

1.1

1.7

—

604.60

iu/ml

—

Congenital malformations of pulmonary and tricuspid valves

0.00

0.21

0.0

2.1

—

Seminoma of testis

0.00

0.21

0.0

1.4

—

Other congenital malformations, not elsewhere classified

0.00

0.21

0.0

2.0

—

Congenital malformations of eyelid, lacrimal apparatus and orbit

0.00

0.21

0.0

2.0

—

Atypical virus infections of central nervous system

0.00

0.21

0.0

2.2

—

Seminoma of testis, including Hilmo

0.00

0.21

0.0

1.8

—

Burns classified according to extent of body surface involved

0.00

0.21

0.0

2.2

—

0.00

0.21

0.0

2.1

—

Prominent ears

0.00

0.21

0.0

2.0

—

Cleft palate

0.00

0.21

0.0

1.9

—

Migraine with aura, drug-induced

0.00

0.21

0.0

2.1

—

Caries in Clefts patients

0.00

0.21

0.0

2.1

—

Phakomatoses, not elsewhere classified

0.00

0.21

0.0

2.1

—

Other chondrocalcinosis

0.00

0.21

0.0

1.0

—

Unspecified maternal hypertension

0.00

0.21

0.0

2.8

—

Somnolence

0.00

0.21

0.0

2.0

—

Diseases caused by chlamydiae

0.00

0.21

0.0

2.1

—

Systemic sclerosis (FG)

0.00

0.21

0.0

2.9

—

Coarctation of the aorta

0.00

0.21

0.0

2.0

—

Other and unspecified trigeminal disorders

0.00

0.21

0.0

2.3

—

Dislocation of lens

0.00

0.21

0.0

1.8

—

Other disorders of breast and lactation associated with childbirth

0.00

0.21

0.0

1.9

—

Other congenital malformations of ear

0.00

0.21

0.0

1.8

—

Personality and behavioural disorders due to brain disease, damage and dysfunction

0.00

0.21

0.0

1.9

—

Non-allergic asthma (mode), excluding more controls

190

1.15

0.20

1.2

1.8

—

643.00

—

Tonsillectomy and adenotomy

535

1.07

0.20

1.3

1.8

—

463.80

iu/ml

—

Other specified and unspecified strabismus

0.00

0.20

0.0

1.9

—

Other and unspecified injuries of abdomen, lower back and pelvis

0.00

0.20

0.0

1.8

—

Congenital malformations of breast

0.00

0.20

0.0

2.4

—

Congenital malformations of breast

0.00

0.20

0.0

2.4

—

Trigeminal neuralgia

1.18

0.19

1.0

2.0

—

Fibromyalgia

1.24

0.18

1.0

1.8

—

Diseases of middle ear and mastoid

617

1.06

0.18

1.5

1.7

—

423.45

iu/ml

—

Noninflammatory disorders of female genital tract

261

1.08

0.17

2.2

1.6

—

466.20

iu/ml

—

Atopic dermatitis, strict definition

351

1.09

0.17

1.4

1.7

—

426.13

—

Synovial cyst of popliteal space [Baker]

0.71

0.16

1.0

1.7

—

Acute bronchitis

457

1.07

0.16

1.9

1.5

—

507.17

iu/ml

—

Methotrexate

151

0.86

0.15

1.7

1.4

—

Other/unspecified enthesopathies, not elsewhere classified

0.79

0.15

2.0

1.8

—

iu/ml

—

Pre-eclampsia or poor fetal growth

292

1.09

0.15

1.2

1.7

—

500.20

—

Hypothyroidism, other/unspecified

123

777

1.04

0.14

1.6

89.00

580.50

iu/ml

—

Disorders of vitreous body and globe

581

1.06

0.14

1.5

1.6

—

270.20

iu/ml

—

Other and unspecified disorders of vitreous body

472

1.07

0.14

1.6

1.5

—

270.20

iu/ml

—

Suppurative and unspecified otitis media

417

0.93

0.14

1.2

1.8

—

463.80

iu/ml

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

126

797

1.04

0.13

1.6

89.00

580.50

iu/ml

—

Haemorrhage in early pregnancy

269

1.09

0.13

1.4

1.7

—

489.80

iu/ml

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

376

0.93

0.13

1.3

1.6

—

604.60

iu/ml

—

Effects of foreign body entering through natural orifice

306

1.08

0.12

1.7

—

604.60

—

Acute suppurative otitis media

304

1.07

0.12

1.1

1.8

—

482.57

iu/ml

—

Other and unspecified effects of external causes

336

1.07

0.12

1.8

1.7

—

426.13

—

Other spirochaetal diseases

353

0.93

0.11

1.0

1.6

—

602.40

—

Spirochaetal infections, other/unspecified

352

0.94

0.10

1.0

1.6

—

602.40

—

Plantar fascial fibromatosis

1.15

0.10

3.5

1.8

—

Stroke, excluding SAH

524

0.96

0.09

1.2

1.7

—

47143335.86

iu/ml

—

Lyme disease

350

0.94

0.09

1.0

1.6

—

602.40

—

Special screening examination for other diseases and disorders

113

0.88

0.08

1.0

1.3

—

Hyperlipidaemia, other/unspecified

396

1.05

0.08

1.9

1.6

—

270.20

iu/ml

—

L02BB Anti-androgens

0.86

0.07

1.4

1.5

—

Angina pectoris

466

1.03

0.06

1.4

1.7

—

55000225.17

iu/ml

—

Other spirochaetal diseases

355

0.96

0.06

1.0

1.6

—

602.40

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

354

0.96

0.05

1.5

1.7

—

560.67

—

Other bursopathies

130

1.08

0.04

1.0

1.6

—

Other shoulder lesions

1.10

0.04

2.7

1.8

—

All dysplastic lesions of the cervix uteri

237

0.96

0.02

1.4

1.7

—

500.20

iu/ml

—

Allergic asthma (mode)

246

1.03

0.02

1.1

1.8

—

636.57

iu/ml

—

Allergic asthma (mode), excluding more controls

247

1.03

0.01

1.1

1.8

—

636.57

iu/ml

—

Disorders of vitreous body

572

1.01

0.01

1.6

—

270.20

iu/ml

—

Stroke, including SAH

560

1.01

0.01

1.2

1.7

—

47143335.86

iu/ml

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

543

0.99

0.00

1.6

—

398.71

iu/ml

—

Asthma and allergy

135

1.02

0.00

1.0

2.1

—

649.00

—

Asthma and allergy, excluding more controls

134

1.03

0.00

1.0

2.1

—

649.00

—

Viral and other specified intestinal infections

239

1.02

0.00

1.4

1.7

—

601.20

iu/ml

—

Conjunctivitis (acute, non atopic)

331

0.99

0.00

1.4

1.5

—

604.60

—

All dysplastic lesions of the cervix uteri, vagina or vulva

271

1.02

0.00

1.5

1.6

—

500.20

iu/ml

—

Rheumatoid arthritis, including avohilmo

435

0.99

0.00

1.5

1.7

—

558.50

—

Chalazion

117

1.03

0.00

2.9

1.6

—

Palmar fascial fibromatosis [Dupuytren]

142

0.99

0.00

1.8

1.6

—

Endometriosis

247

1.00

0.00

2.3

1.6

—

466.20

iu/ml

—

Other osteochondrodysplasias

0.00

0.0

2.5

—

Contact with other and unspecified heat and hot substances

0.00

0.0

2.8

—

Other specified transport accidents

0.00

0.0

2.1

—

Injury of nerves at ankle and foot level

0.00

0.0

2.5

—

Intercostal neuropathy

0.00

0.0

2.3

—

Injury of cranial nerves

0.00

0.0

3.0

—

Brachial plexus disorders

0.95

0.00

2.9

1.5

—

Marfan's syndrome

0.00

0.0

2.8

—

Burns and corrosions of multiple body regions

0.00

0.0

1.4

—

Abnormal pulmonary venous return

0.00

0.0

1.0

—

Xanthelasma of eyelid

0.00

0.0

2.4

—

Atrioventricular septal defect

0.00

0.0

1.4

—

Spontaneous rupture of synovium and tendon

0.90

0.00

2.4

1.7

—

iu/ml

—

Other bursitis, not elsewhere classified

0.00

0.0

1.2

—

Malignant neoplasm of lip, including Hilmo

0.00

0.0

1.0

—

Disorders of aromatic amino-acid metabolism

0.00

0.0

3.0

—

Acute mastoiditis

0.00

0.0

1.4

—

Chorioretinal scars

0.00

0.0

2.8

—

Congenital malformations of posterior segment of eye

0.00

0.0

1.0

—

Sequelae of tuberculosis

0.00

0.0

2.0

—

Birth asphyxia

0.00

0.0

2.3

—

Meningococcal infection

0.00

0.0

2.7

—

Lesion of femoral nerve

0.00

-0.00

0.0

3.2

—

Other abnormal auditory perceptions

0.00

-0.00

0.0

2.3

—

Disorders of purine and pyrimidine metabolism

0.00

-0.00

0.0

2.4

—

Impaction of intestines

0.00

-0.00

0.0

2.8

—

Palatinal maxillary operation

0.00

-0.00

0.0

1.0

—

Acne conglobata

0.00

-0.00

0.0

2.8

—

Erectile dysfunction

0.92

-0.00

1.4

—

Palatinal maxillary canine

0.00

-0.00

0.0

1.0

—

Accessory breast

0.00

-0.00

0.0

2.8

—

Mandibular hypoplasia

0.00

-0.00

0.0

3.0

—

Fall involving playground equipment

0.00

-0.00

0.0

1.1

—

Constitutional tall stature

0.00

-0.00

0.0

1.0

—

Congenital malformations of anterior segment of eye

0.00

-0.00

0.0

2.3

—

Frontotemporal dementia, wide, incl. Pick's disease

0.00

-0.00

0.0

1.0

—

Other disorders affecting eyelid function

0.00

-0.00

0.0

2.8

—

Congenital ichthyosis

0.00

-0.00

0.0

2.8

—

Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease

0.00

-0.00

0.0

1.2

—

Thyrotropin deficiency

0.00

-0.00

0.0

2.4

—

Calcific tendinitis

0.00

-0.00

0.0

1.4

—

Carcinoma in situ of oral cavity, oesophagus and stomach

0.00

-0.00

0.0

3.2

—

Carcinoma in situ of prostate

0.00

-0.00

0.0

1.4

—

Other congenital malformations of heart

0.00

-0.00

0.0

1.1

—

Pleural plaque with presence of asbestos

0.91

-0.00

1.0

1.5

—

Generalized pustular psoriasis

0.00

-0.00

0.0

3.0

—

Benign neoplasm: Orbit, unspecified

0.00

-0.00

0.0

2.4

—

Spermatocele

0.98

-0.00

1.9

1.6

—

iu/ml

—

Olecranon bursitis

0.94

-0.00

3.6

1.5

—

Panniculitis, unspecified

0.00

-0.00

0.0

1.3

—

Ectopic testis

0.00

-0.00

0.0

1.0

—

Congenital malformations of cardiac chambers and connections

0.00

-0.00

0.0

1.0

—

Aphakia

0.00

-0.00

0.0

2.3

—

Malignant neoplasm of other and unspecified parts of mouth, including Hilmo

0.00

-0.00

0.0

1.0

—

Other corneal oedema

0.00

-0.00

0.0

1.2

—

Feeding problems of newborn

0.00

-0.00

0.0

1.2

—

Infarction of spleen

0.00

-0.00

0.0

2.8

—

Other infections specific to the perinatal period

0.00

-0.00

0.0

1.0

—

Congenital malformations of great veins

0.00

-0.00

0.0

1.0

—

Congenital ptosis

0.00

-0.00

0.0

2.8

—

Neurofibromatosis, type 1

0.00

-0.00

0.0

3.0

—

Malignant neoplasm of other and unspecified parts of mouth

0.00

-0.00

0.0

1.0

—

Other mosquito-borne viral fevers

0.00

-0.00

0.0

2.9

—

Hereditary deficiency of other clotting factors

0.00

-0.00

0.0

2.7

—

Malignant neoplasm of base of tongue, including Hilmo

0.00

-0.00

0.0

3.0

—

Congenital malformations of ear causing impairment of hearing

0.00

-0.00

0.0

3.0

—

Divergent concomitant strabismus

1.01

-0.00

2.4

1.5

—

Malignant neoplasm of base of tongue

0.00

-0.00

0.0

2.4

—

Other congenital malformations of kidney

0.00

-0.00

0.0

2.8

—

Melanoma in situ of lower limb, including hip

0.00

-0.00

0.0

2.8

—

Congenital aortic valve stenosis

0.00

-0.00

0.0

2.8

—

Other congenital malformations of female genitalia

0.00

-0.00

0.0

2.4

—

Benign neoplasm: Retina

0.00

-0.00

0.0

2.8

—

Congenital stenosis of pulmonary valve

0.00

-0.00

0.0

2.3

—

Diseases caused by chlamydiae

0.00

-0.00

0.0

2.8

—

Malignant neoplasm of gallbladder, including Hilmo

0.00

-0.00

0.0

1.0

—

Hypospadias

0.00

-0.00

0.0

1.0

—

Rifle, shotgun and larger firearm discharge

0.00

-0.00

0.0

1.4

—

Need for immunization against single bacterial diseases

0.00

-0.00

0.0

2.8

—

Implicit parasitic Sepsis

0.00

-0.00

0.0

1.2

—

Toxoplasmosis

0.00

-0.00

0.0

2.7

—

Gangrene, not elsewhere classified

0.00

-0.00

0.0

1.0

—

Symptoms and signs involving appearance and behaviour

0.00

-0.00

0.0

2.1

—

Synovial hypertrophy, not elsewhere classified

0.00

-0.00

0.0

1.3

—

Corneal pigmentations and deposits

0.00

-0.00

0.0

3.2

—

Cervical root disorders

0.00

-0.00

0.0

2.5

—

Acquired keratosis [keratoderma] palmaris et plantaris

0.00

-0.00

0.0

2.4

—

Contact with other specified venomous animals

0.00

-0.00

0.0

3.0

—

Unattended death

0.00

-0.00

0.0

1.3

—

Other and unspecified disorders of pigmentation

0.00

-0.00

0.0

2.5

—

Complex cardiac defects

0.00

-0.00

0.0

1.4

—

Non-seminoma of testis, including Hilmo

0.00

-0.00

0.0

1.2

—

Other and unspecified heterotropia

0.00

-0.00

0.0

1.2

—

Crushing injury of ankle and foot

0.00

-0.00

0.0

1.4

—

Tarsal tunnel syndrome

0.00

-0.00

0.0

2.2

—

Acromegaly and pituitary gigantism

0.00

-0.00

0.0

2.8

—

Effects of heat and light

0.00

-0.00

0.0

2.7

—

Epidural haemorrhage

0.00

-0.00

0.0

1.6

—

Tetraplegia

0.00

-0.00

0.0

2.4

—

Toxic effect of corrosive substances

0.00

-0.00

0.0

2.8

—

Varus deformity, not elsewhere classified

0.00

-0.00

0.0

2.0

—

Acute myringitis

0.00

-0.00

0.0

2.8

—

Other congenital malformations of urinary system

0.00

-0.00

0.0

3.0

—

Special screening examination for neoplasms

0.86

-0.00

1.0

1.5

—

Left side

0.00

-0.00

0.0

2.8

—

Unspecified threat to breathing

0.00

-0.00

0.0

2.2

—

Vascular dementia (mixed)

0.00

-0.00

0.0

1.0

—

Injury of nerves and lumbar spinal cord at abdomen, lower back and pelvis level

0.00

-0.00

0.0

3.4

—

Other bursal cyst

0.00

-0.00

0.0

1.1

—

Benign neoplasm: Pharynx, unspecified

0.00

-0.00

0.0

3.0

—

Liveborn infants according to place of birth

0.00

-0.00

0.0

1.1

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS